Friday, January 21, 2022
Researcher Calls Out Censorship After Journal Pulls COVID-19 Vaccine Adverse Events Analysis
Jessica Rose didn’t ask for any of this. She started to analyze data on adverse reactions after COVID-19 vaccines simply as an exercise to master a new piece of software. But she couldn’t ignore what she saw and decided to publish the results of her analysis. The next thing she knew, she was in a “bizzarro world,” she told The Epoch Times.
A paper she co-authored based on her analysis was withdrawn by the academic journal Elsevier under circumstances that raised eyebrows among her colleagues. The journal declined to comment on the matter.
Rose received her PhD in computational biology from the Bar-Ilan University in Israel. After finishing her post-doctoral studies on molecular dynamics of certain proteins, she was looking for a new challenge. Switching to a new statistical computing software, she was looking for an interesting data set to sharpen her skills on. She picked the Vaccine Adverse Event Reporting System (VAERS), a database of reports of health problems that have occurred after a vaccination and may or may not have been caused by it.
She said she wasn’t looking for anything in particular in the data. “I don’t go in with questions,” she said.
What she found, however, was disturbing to her.
VAERS has been in place since 1990 to provide an early warning signal that there might be a problem with a vaccine. Anybody can submit the reports, which are then checked for duplicates. They are largely filed by health care personnel, based on previous research. Usually, there would be around 40,000 reports a year, including several hundred deaths.
But with the introduction of the COVID-19 vaccines, VAERS reports went through the roof. By Jan. 7, there were over a million reports, including more than 21,000 deaths. Other notable issues include over 11,000 heart attacks, nearly 13,000 cases of Bell’s palsy, and over 25,000 cases of myocarditis or pericarditis.
Rose found the data alarming, only to realize authorities and even some experts were generally dismissing it.
“Clearly, there’s no concern [among these authorities and experts] for people who are suffering adverse events,” she said.
The usual arguments against the VAERS data have been that it’s unverified and unreliable.
Rose, however, sees such arguments as irrelevant—VAERS was never meant to provide definitive answers, it’s meant to give early warning and, as she sees it, it’s doing just that.
“It’s emitting so many safety signals and they’re being ignored,” she said.
She teamed up with Peter McCullough, an internist, cardiologist, and epidemiologist, to write a paper on VAERS reports of myocarditis in youth—an issue already acknowledged as a side effect of the vaccination, though usually described as rare.
As of July 9, they found 559 VAERS reports of myocarditis, 97 among children ages 12–15. Some of them may have been related to COVID itself, which can also cause heart problems, but there were too many cases to dismiss the likelihood the vaccines were involved, according to the authors.
“Within 8 weeks of the public offering of COVID-19 products to the 12–15-year-old age group, we found 19 times the expected number of myocarditis cases in the vaccination volunteers over background myocarditis rates for this age group,” the paper said.
After two weeks, on Oct. 15, the paper disappeared from the Elsevier website, replaced by a notice of “Temporary Removal.” Not only weren’t the authors told why, they weren’t informed at all, according to Rose.
“It’s unprecedented in the eyes of all of my colleagues,” she said.
When they brought up the issue with the journal, they were first told the paper was pulled because it wasn’t “invited,” Rose said. That was shot down as irrelevant by McCullough, who threatened to sue for breach of contract. The journal then turned to its terms of use, saying it has the right to refuse any paper for any reason.
It’s still not clear why the paper was pulled. “I do apologise, but Elsevier cannot comment on this enquiry,” said Jonathan Davis, the journal’s communications officer, in an email to The Epoch Times.
In late November, the paper was replaced by a notice that the “article has been withdrawn at the request of the author(s) and/or editor.”
“It just feels like weird censorship that isn’t really justified,” Rose said.
The paper’s conclusions are not necessarily controversial. A recent Danish study concluded, for example, an elevated risk of myocarditis for young people following the Moderna COVID vaccine.
It’s common, however, even for papers that examine potential issues with the vaccines to frame their results in a way that still endorses vaccination. “That’s what you have to say to get your work published these days,” Rose said.
Her paper did no such thing.
“As part of any risk/benefit analysis which must be completed in the context of experimental products, the points herein must be considered before a decision can be made pertaining to agreeing to 2-dose injections of these experimental COVID-19 products, especially into children and by no means, should parental consent be waived under any circumstances to avoid children volunteering for injections with products that do not have proven safety or efficacy,” the paper said.
The paper also called the vaccines “injectable biological products”—a reference to the fact that they are distinct from all other traditional vaccines.
A traditional vaccine uses “whole live or attenuated pathogens” while the COVID vaccines use “mRNA in lipid nanoparticles,” Rose explained via email. She said the lipid nanoparticles include “cationic lipids which are highly toxic.” Pfizer, the manufacturer of the most popular COVID-19 vaccine in many countries, addressed the issue by saying the dose is sufficiently low to ensure “an acceptable safety margin,” according to the European drug authority, the Committee for Medicinal Products for Human Use (pdf).
Rose also noted that the COVID-19 vaccines haven’t gone “through the 10-15 years of safety testing that vaccines have always had to go through … for obvious reasons.”
By this point, Rose is no longer a dispassionate observer. Reading through countless VAERS reports gave her a window into the hardships of those who believe they’ve been harmed by the vaccines. “I speak for all of those people,” she said.
In the past, 50 reports of deaths in VAERS would prompt authorities to hit the brakes and investigate, Rose said. In her view, that should have happened with the COVID-19 vaccines a year ago.
Not only has that not happened, but it isn’t even clear what would be enough to convince the authorities to do so.
“What’s the cut-off number for the number of deaths?” Rose asked.
The counterargument is that the vaccines save more lives than they cost. But in Rose’s view, this logic is flawed since the vaccines haven’t been around long enough and studied thoroughly enough to tell how many lives they may cost.
It is known, however, that VAERS understates adverse events following vaccination—by a factor of anywhere between 5 and as much as 100, based on some estimates.
Submitting a VAERS report takes about 30 minutes and many medical practitioners simply don’t have the time, Rose said. Some may feel that filing the report may get them labeled as “anti-vaxxers.” Some may simply not associate whatever health issue they’re facing with the vaccination. Some may not even be aware VAERS exists.
It’s unlikely that any significant number of the reports would be fraudulent, she suggested, noting it’s a federal offense to submit a false report.
Rose has now joined the ranks of dissident doctors and researchers skeptical of the official line on the vaccines and the pandemic in general. She described it as something she’s compelled to do despite the disincentives involved.
“We don’t want to be doing this. But it is our duty. Doctors swore an oath to do no harm. And researchers with integrity cannot look away from this,” she said via email.
********************************************
The most vaccinated country in the world is being hit heavily by Omicron
Israel experienced its highest daily number of new Covid cases this week – 71,000 out of a population of 9 million – but the head of country’s health department, Nahman Ash, concedes the number may be up to three times higher. Whichever figure is correct, the trend is certain: case numbers have been rising every day for the past two weeks, as the Omicron wave surges.
“Ninety-eight per cent of our patients are now infected with Omicron,” says Dror Mevorach, who heads the Covid ward at Hadassah hospital in Jerusalem.
As the number of seriously ill patients rises, hospitals are reopening Covid wards and postponing elective surgery. Health bureaucrats and politicians hope this wave will peak before the hospital system overloads.
As a result, Israel is also adopting self-administered rapid antigen tests as its alternative testing method, and a lack of supply has led to queues and rising prices too. Prime Minister Naftali Bennett admitted this was a problem, but said it could be solved.
“We will purchase 50 million more RATs,” he said last week. The finance minister said 20 million would be enough. They appear to have sorted out that issue, as on Tuesday Mr Bennett said the first delivery was due next week. And the main policy change: 25-30 million kits will be distributed for free to certain sectors of the population.
From the start, Israel has been proactive, pioneering mass vaccinations and the third booster shot. Once it became clear that the largest numbers of vaccinated people contracting the Omicron variant were older, Israel last month initiated a fourth vaccine booster for those over 60, as well as frontline medical workers and the immuno-compromised.
As a fourth shot had not been approved by US regulatory authorities, the Sheba Medical Centre near Tel Aviv began a trial, testing its effect on its staff, who have been monitored since December 2020, when they received the first dose of the vaccine. Preliminary results released this week have found only middling results.
“The vaccine, which was very effective against the previous strains, is less effective against Omicron,” said Gili Regev-Yochay, who is leading the trial.
“We see many who receive the fourth dose and are infected with Omicron. Granted, a bit less than in the control group, but there are still a lot of infections. The bottom line is that the vaccine was excellent against the Alpha and Delta variants, but for Omicron it’s not good enough.”
The trial, which follows 150 medical staff, is much smaller than most drug trials, where thousands of participants are tracked for months. But Dr Regev-Yochay says she released the preliminary findings because it’s the only known study of the fourth dose. She added it was still probably beneficial to give a fourth jab to people in higher risk groups including the very elderly, but hinted that perhaps it need not be given to everyone over 60.
More than 500,000 Israelis have received a fourth dose, and Dr Alroy-Preis says with hindsight it was still the right decision. “A five to six fold increase in antibodies is better than nothing and this is the most vulnerable section of the community,” she said.
Israel has also been prescribing the new Pfizer drug Paxlovid. Ruth Ralbag, head of private health fund Clalit, said the new drug was only appropriate for people in the first stages of the disease and could be taken at home. “Covid is teaching us that care at home is the future,” she said.
It seems even a proactive government finds it hard to remain popular during a pandemic. According to the latest polls, 48 per cent of Israelis, frustrated at the high infection rate and repeated quarantines, don’t think the government is doing a good job.
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Thursday, January 20, 2022
Expert skeptical about vaccines
Dr. Peter McCullough – a renowned cardiologist and highly published medical scientist whose confrontation of the government's COVID-19 policies has drawn more than 40 million views on Joe Rogan's podcast – told WND in a video interview Thursday night the official pandemic narrative that has been fiercely guarded by establishment media and social-media censors is "completely crumbling."
That narrative, he said, included "false statements regarding asymptomatic spread, reliance on lockdown and masks – which obviously didn't work – the suppression of early treatment, the mass promotion of vaccines that failed."
"And now here we are, almost in complete free fall," McCullough said, referring to the record number of COVID-19 cases as officials acknowledge the vaccines don't prevent infection or transmission.
McCullough noted that in California, with the more contagious but much milder omicron variant now dominant, health care workers who tested positive for COVID-19 and had symptoms were told to go back to work.
"With that, I think that's it. I think that's the end. The narrative has crumbled. People don't want these vaccines," McCullough said. "The vaccines should be pulled off the market. They clearly are not solving the problem."
The focus, he said, should be on "treating high-risk patients who develop symptoms" with some of the early treatments that he and other physicians around the world have found to be effective, including ivermectin and a new drug granted emergency use authorization by the FDA, Paxlovid.
McCullough cited a study from Denmark and data from the U.K.'s health agency showing that the vaccines have zero effectiveness against omicron.
Completing this poll entitles you to WND news updates free of charge. You may opt out at anytime. You also agree to our Privacy Policy and Terms of Use.
"That's not misinformation," he said. "I'm just quoting the data. All of this can be looked up. Fact-checkers can look at it. I know I'll never have any problems with allegations of misinformation, because I just quote the data."
President Biden clearly had McCullough in mind when on Thursday he urged social media companies and media outlets to "please deal with the misinformation and disinformation that's on your shows. It has to stop."
McCullough pointed out his work has been relied upon by courts across the nation, including the U.S. Supreme Court, and he has testified to the U.S. Senate and will be back there later this month.
https://www.zerohedge.com/covid-19/dr-peter-mccullough-official-covid-narrative-has-crumbled
**********************************************Fourth shot of Covid vaccine is NOT enough against Omicron
Even a fourth dose of current Covid vaccines is not enough to prevent Omicron infection, according to preliminary results from a trial in Israel.
The study of more than 270 medical staff found that the fourth shot only raised antibodies 'a little' compared to those who were triple-jabbed.
And those in the four jabs group were only 'a bit less' likely to test positive for the mutant strain than the control group.
The findings were true for a fourth dose of both Pfizer and Moderna, and will reignite the debate about whether constant boosting is necessary.
Researchers from the Sheba Medical Center in Tel Aviv, who ran the trial, said those infected in the study had very mild symptoms or none at all.
Dr. Gili Regev-Yochay, the lead researcher of the trial, told a press conference: 'These are very preliminary results. This is before any publication.
'But we're giving it out since we understand the urgency of the public to get any information possible about the fourth dose.'
The findings will likely reignite the debate around how often Covid vaccine boosters are needed.
A UK Government adviser today became the latest senior figure to warn against repeated mass vaccinations, recommending a targeted approach like for flu.
And last week, European Union regulators claimed that boosting too frequently could actually weaken the immune system.
The World Health Organization has called on vaccine makers to make variant-proof jabs to avoid countries having to revaccinate every few months.
Israel was the first country in the world to roll out boosters last year and became the only nation to start dishing out fourth shots last month to combat Omicron.
Studies have since shown that three jabs are holding up well against serious illness, offering about 88 per cent protection from hospitalisation, even if Omicron can slip past the immune system and cause an infection more easily.
More than half a million people in those two risk groups have been quadruple-jabbed so far. But she admitted the small extra benefit was not enough to justify a wider rollout to the whole adult population.
************************************************
Blood thinner could be used to treat and stop transmission of COVID-19
Patients at four hospitals in NSW and Victoria are set to undergo treatment with a cheap, readily available drug that scientists believe can dramatically improve outcomes for those infected with COVID-19.
Heparin is a common blood thinner that has been in use for decades. Australian National University researchers are coordinating multiple studies aiming to prove it is effective in preventing severe disease among coronavirus patients when inhaled directly into the lungs.
ANU study lead Professor Frank van Haren said initial results indicate the drug could be “a promising treatment” and also “a possible preventative against the virus” with breathing and oxygen levels improving in 70 per cent of patients after they inhaled a course of heparin.
“If it is as effective as our early results suggest, it could have a major impact in our fight against COVID,” Professor van Haren said.
Researchers around the world are tracking hospital patients infected with SARS-CoV-2 in 13 countries who were given doses of inhaled heparin, which is administered through an inhaler similar to the ones used to treat asthma.
When the study began, Australia did not have enough people infected with COVID-19 to test the drug on patients here, but now trials are beginning at St George Hospital in Kogarah, the John Hunter Hospital in Newcastle, Sydney’s Royal North Shore Hospital and St Vincent’s Melbourne.
A randomised, peer reviewed study of 98 patients, to be published in the British Journal of Clinical Pharmacology on Thursday, found heparin was safe, with no concerning side effects among patients who inhaled a therapeutic dose of the drug.
While the larger, ongoing international study would provide a “definitive” answer about the treatment’s efficacy, Professor van Haren said the new safety findings were crucial.
“It’s super important to know that the new treatment and new way of giving something is actually safe, that it doesn’t do any harm,” he said. “There is still an urgent need for an effective treatment of COVID-19.”
Co-author Professor Clive Page, from King’s College London, who is co-leading the global studies, said inhaled heparin had antiviral properties “which work by binding to the spike proteins the coronavirus uses to enter the cells of the body.”
“Inhaled heparin effectively stops the virus infecting cells in the lungs and could also stop people from getting the virus from others,” Professor Page said.
“It also works as an anti-inflammatory drug; the medicine has the ability to calm everything down when the body is mounting an exaggerated response to the virus.”
Professor van Haren said he hoped the drug’s efficacy could be proven quickly, saying it could be used widely within months if early results held up – easing the strain on hospitals by reducing the number of patients needing to be admitted to intensive care units.
“Most COVID experts agree that vaccination alone is not going to stop the pandemic. This could really assist in poorer countries where vaccination is challenging and we think it could help frontline workers who could use it as a preventative measure,” he said.
Professor van Haren said the team was now collecting more evidence that inhaled heparin worked and that “once we have this evidence, heparin via inhalation, could be an option to treat COVID-19 patients, everywhere, within months”.
Heparin, which is normally administered via injection, is a blood thinner used to treat and prevent blood clots across the world and is widely available.
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Wednesday, January 19, 2022
Fauci warns that Omicron may NOT be the 'end' of the pandemic and there is a 'high probability' another variant could emerge' that would evade immunity
Fauci, director of the National Institute of Allergies and Infectious Disease, told the Davos Agenda virtual event Monday that 'natural vaccination' - or immunity via previous infection - might not be as effective as some believe.
Like the emergence of Omicron, there is potential for a new variant to emerge in the future that can bypass the natural immunity provided by infection from the new strain.
He says that even if Omicron - which has caused a massive surge in new cases worldwide but is not as severe or deadly as its predecessors - is the final strain of Covid, it will likely become endemic.
His warning runs counter to the positive predictions coming from some officials in the UK who believe that the virus could have a 'flu-type' relationship with people by the end of the year based on its current spread.
'I would hope that that's the case. But that would only be the case if we don't get another variant that eludes the immune response of the prior variant,' Fauci said.
Fauci has previously made grim projections about new Covid variants, and was even correct about a variant like Omicron emerging.
In August, when the Delta variant was first rising in the U.S., Fauci warned that with transmission of Covid so rampant it was likely that a vaccine resistant variant would eventually emerge.
Months later, than variant did come about, when South African health officials discovered the highly infectious Omicron variant in late November.
He fears that there is a chance another variant emerges that has mutated in a way that allows it to get around protection provided by recovering from Omicron.
Covid becoming endemic as a result of Omicron has become a common theory among health experts and officials, and has served as a beacon of hope for the population suffering through the recent surge.
Omicron is burning through people so quickly, causing daily Covid cases to hit records almost everywhere in the world, that it could soon run out of people to infect.
The U.S.'s daily case average eclipsed 800,000 for the first time over the weekend, with the height of the Omicron surge now reaching four times as many cases as the peak of the Delta wave. Disparities in case figures have not translated into more deaths, though, with the 1,839 deaths being recorded every day in America - the most since early October - is still far below the 3,200 deaths per day being averaged at the peak of the Delta surge in late September.
Cases also seem to be reaching a peak. Week-to-week case growth nationwide is slowing. New daily cases are only up seven percent over the past week, compared to a 75 percent increase the week before. New York and New Jersey were struck hard and fast by the variant last month, but cases in the neighboring states are now decreasing over the past two weeks - down 14 percent and 20 percent respectively.
Dr Vivek Murthy, America's surgeon general, warns that the peak may not be as near as some believe. He told CNN on Sunday that not every state will experience was is currently going on along the east coast.
'There are parts of the country -- New York, in particular, and other parts of the Northeast -- where we are starting to see a plateau, and in some cases, an early decline in cases,' Murthy said.
'The challenge is that the entire country is not moving at the same pace,'
'The Omicron wave started later in other parts of the country, so we shouldn't expect a national peak in the next coming days. The next few weeks will be tough.'
New Jersey, once among the leader in infection rate, is now seeing cases decline - signaling this surge is coming to an end.
Its neighbor, New York, and Maryland - which is experiencing a seven percent decline in daily cases - are also among the only three states in America where cases are going down.
The rate of case growth in state where cases are increasing is starting to slow, though. Last week, almost every state in America was recording a two-week doubling of cases. As of Monday morning, only 35 states have logged an increase of more than 100 percent in the past 14 days.
Some states that were once hotspots look like they could soon join the ranks of states posting decreasing cases. Georgia was once one of the hardest hit states in America by the recent Omicron surge, mainly fueled by an outbreak in the Atlanta area. The Peach state has seen a rapid decline in growth, though, with cases only up 34 percent over the past two weeks.
Neighboring Florida has quickly dropped off the leaderboard of states with the highest case growth, with the Sunshine state logging a 35 percent increase in cases over the past two weeks. Florida numbers can sometimes be misleading, though, due to the inconsistent nature of case reporting in the state.
https://www.dailymail.co.uk/health/article-10411817/Fauci-warns-Omicron-not-end-Covid.html
************************************************French parliament approves law that will exclude unvaccinated people from all restaurants, sports areas, tourist sites and even trains
The French parliament has approved a law that will exclude unvaccinated people from all restaurants, sports areas, tourist sites and even trains.
President Emmanuel Macron has faced criticism that the new vaccine pass is overkill and will do little to slow hospitalisations because 91 per cent of the population are already jabbed against Covid-19.
Up until now, a Covid-19 pass has been required in France to go to most public sites throughout the country, but unvaccinated people have been allowed in if they show a recent negative test or proof of recent recovery.
But the new law, which applies to everyone aged 16 and over, requires full vaccination and removes the test option, effectively barring unvaccinated people from such venues.
Some exceptions could be made for those who have recently recovered from Covid-19 but the law, set to come into force by the end of the week, also imposes tougher fines for fake passes and allows ID checks to avoid fraud.
It is the central measure of government efforts to protect hospitals amid record numbers of Covid infections driven by the highly contagious Omicron variant.
The plans have faced fierce resistance from anti-vaccination campaigners and far-right and far-left groups, but was backed by the government which has a majority in parliament.
Macron's government is hoping the new pass will be enough to limit the number of patients filling up strained hospitals nationwide without resorting to a new lockdown.
New confinement measures would strike another blow to the economy, and could also cloud Macron's chances of re-election in the April 10 presidential vote.
More than 76 per cent of French ICU beds are occupied by coronavirus patients, most of them unvaccinated, and some 200 people with the virus are dying every day.
Like many countries, France is in the grip of an Omicron wave, recording more than 2,800 positive cases per 100,000 people over the past week.
The National Assembly adopted the law by a vote of 215-58. Macron, 44, had hoped to push the Bill through faster, but it was slightly delayed due to resistance from politicians both on the right and left and hundreds of proposed amendments.
Far-right leader Marine le Pen wrote on Twitter yesterday that, if elected, she would 'remove this useful and draconian measure', in reference to the new legislation.
Left wing politician François Ruffin said the vaccine pass made unvaccinated people 'second class citizens' and asked 'what have you done with our souls?'
Christophe Castaner, a member of Macron's La Republic en Marche party, rebutted Ruffin, saying 'the fight you are leading is already lost', citing a recent increase in vaccine uptake.
The new law comes after Macron said earlier this month he wanted to 'p*** off' unvaccinated people by making their lives so complicated they would end up getting jabbed.
He made the cutting remark while responding to a nurse during a question and answer session with readers of Le Parisien on how the government will handle non-vaccinated people.
'By – and I’m sorry for putting it this way – by p***ing them off even more,' Macron said.
'I’m generally opposed to the French being p****d off. I complain all the time about administrative blockages. But when it comes to the non-vaccinated, I’m very keen to pi** them off. So we’re going to do it, the end. That’s our strategy.'
The phrase prompted howls of condemnation from rivals and forced parliament to suspend a debate on a Covid bill on January 5 as opposition lawmakers demanded explanations from Macron.
But the government backed Macron. 'Who is pissing off who today?', government spokesperson Gabrial Attal said, quoting health workers struggling to cope or businesses hurt by the pandemic. 'It's those who refuse the vaccine.'
'A president cannot say such things,' Christian Jacob, chair of the conservative Les Republicans party, told parliament on January 5 as it discussed the new legislation.
'I'm in favour of the vaccine pass but I cannot back a text whose objective is to 'p*** off' the French,' Jacob said. 'Is that your objective, yes or no? We cannot keep debating without having a clear answer on that.'
'A president shouldn't say that,' Le Pen responded on Twitter. 'Emmanuel Macron is unworthy of his office.'
In the Le Parisien interview, Macron, who has consistently called on everyone in France to get vaccinated, also called unvaccinated people irresponsible and - in another remark criticised by some voters and the opposition, that 'irresponsible people are no longer citizens'.
He said he aims to irritate the unvaccinated into submission, rather than round them up and prosecute them.
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Tuesday, January 18, 2022
Doctor treated as insane and dangerous for questioning conventional Covid treatment
She treated Covid-19 patients with Ivermectin and hydroxychloroquine
A doctor with decades of experience can’t practice medicine after her license was temporarily suspended over complaints that she shared coronavirus misinformation, according to a Maine licensing board.
The board has ordered her to undergo a neuropsychological evaluation, it said.
Dr. Meryl J. Nass, who got a license to practice medicine in Maine in 1997, had her license “immediately” suspended for 30 days after a board investigation and review of complaints against her on Jan. 12, according to a suspension order from the Maine Board of Licensure in Medicine.
Nass, who’s an internist in Ellsworth, must “submit” to an evaluation by a “Board-selected psychologist” on Feb. 1, the board’s evaluation order issued Jan. 11 said.
“I have no comment about submitting to a neuropsych exam, except that the board ordered me to do so on shaky grounds,” Nass told McClatchy News, adding that she’s had her license for a total of 41 years.
“The information received by the Board demonstrates that Dr. Nass is or may be unable to practice medicine with reasonable skill and safety to her patients by reason of mental illness, alcohol intemperance, excessive use of drugs, narcotics, or as a result of a mental or physical condition interfering with the competent practice of medicine,” the evaluation order states.
The complaints against Nass include how the board was told she engaged in “public dissemination of ‘misinformation’” about COVID-19 and vaccinations “via a video interview and on her website,” the board said about the October 26, 2021 complaint. It lists several comments Nass made that were subject to the board’s investigation.
Roughly 10 days later, the board got another complaint about Nass “spreading COVID and COVID vaccination misinformation on Twitter,” it said.
Nass called “disinformation and misinformation” a “fuzzy concept” that the board hasn’t defined for her, she said. “There’s no law that says doctors can’t express their educated opinion on any subject.”
Other grounds for her suspension include how Nass treated COVID-19 patients with Ivermectin and hydroxychloroquine, according to the board.
The board noted that Ivermectin isn’t Food and Drug Administration “authorized or approved” as a treatment for COVID-19 in the suspension order.
Ivermectin is used as a parasitic treatment for animals, according to the FDA.
“For humans, ivermectin tablets are approved at very specific doses to treat some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea,” the agency explains online.
Additionally, it noted the FDA “revoked’ emergency use authorization for hydroxychloroquine since it “may not be effective” against COVID-19.
Hydroxychloroquine is FDA approved for malaria and certain autoimmune conditions.
On Dec. 19, a physician notified the board that Nass diagnosed a sick, unvaccinated patient “‘over the phone’” with COVID and prescribed 5 days of Ivermectin,” the board said. This patient had to be hospitalized for COVID-19.
With another patient, Nass is accused of emailing the board about another COVID-19 patient saying she was “forced” to “provide misinformation” in order to obtain hydroxychloroquine.
The board said Nass told them during a Zoom meeting that she “lied and said the patient had Lyme disease and so the pharmacist dispensed the medication only because I lied.”
On Dec. 31, a Certified Nurse Midwife reported that Nass prescribed one of her pregnant patients who tested COVID-19 positive with hydroxychloroquine earlier in 2021, according to the board.
Nass said she believes vaccines are “preventive, but they don’t work anymore against the omicron variant.”
Dr. Anthony Fauci, the nation’s leading infectious disease expert, says otherwise.
Omicron “will ultimately find just about everybody” Fauci said on Jan. 11, CNN reported. But those who are vaccinated and boosted “will very likely, with some exceptions, do reasonably well in the sense of not having hospitalization and death.”
Unvaccinated individuals are “going to get the brunt of the severe aspect of this,” Fauci said
On her blog, Nass called her license suspension a “witchhunt.”
Nass’ license is suspended until Feb. 11 “pending further Board action at an adjudicatory hearing,” the suspension order said.
She said that this hearing can be “extended by either party.”
Because of her suspension, her practice in Ellsworth was shut down where she said she takes care of chronically ill patients as well as COVID-19 patients. Ellsworth is located about 100 miles east of Augusta.
The board said that her continuing to practice as a physician “constitutes an immediate jeopardy to the health and physical safety of the public who might receive her medical services, and that it is necessary to immediately suspend her ability to practice medicine in order to adequately respond to this risk.”
https://www.miamiherald.com/news/coronavirus/article257335847.html
************************************************Liberal State Allows COVID-Positive Health Care Workers to STAY AT WORK
Of all of the asinine ways in which we’ve spent the last two years trying to control the coronavirus crisis, and with the gamut of precautions that we’ve had to fight through just to live our normal lives, you would think that the powers that be wouldn’t be quick to just flips a switch and turn it all off.
No, they’ve spent months attempting to convince us of all manner of doom headed our way, lest we choose not to abide by their ever-changing sets of rules.
As the omicron variant surges, however, some of the nation’s most liberal locales are now throwing all caution to the wind, and in an alarming manner.
Daylong waits in the emergency room. No one to answer the phones. No one to take out the trash. And more patients arriving each day.
That’s the scene playing out at some hospitals across Southern California as the Omicron-fueled surge of COVID-19 contributes to a crippling shortage of doctors, nurses and other healthcare workers. While Omicron is causing significantly fewer serious illnesses than last year’s winter surge, the unprecedented number of people becoming infected has left the medical infrastructure on edge.
So what’s their brilliant plan?
State officials are attempting to address California’s staffing shortage through a sweeping policy change that allows asymptomatic healthcare workers who have tested positive for the coronavirus to return to work immediately. The policy, set to remain in place through Feb. 1, is designed to keep many healthcare workers on the job at a time when hospitals are expecting more patients.
Some experts say California’s stance is an unorthodox yet necessary solution to a difficult problem. Yet many healthcare workers and community members say the policy is not only ill-advised, it’s potentially dangerous.
And why wouldn’t they be upset? This new guidance seems to fly in the face of just about every bit of advice we’ve received previous to now.
Leave it to California…
https://steadfastdaily.com/liberal-state-allows-covid-positive-health-care-workers-to-stay-at-work/
***********************************************SCOTUS to the rescue
Medical experts are saying it’s time for the Biden administration to rethink its failing COVID policy. By the end of the week, another Quinnipiac University presidential performance poll was released. Biden’s approval numbers continue to plummet.
To cement his “week from hell”, Biden watched as the U.S. Supreme Court struck down his tyrannical attempt to federally mandate vaccines on businesses across the country. It was one of the most ill-advised attempts at government health control ever.
SCOTUS clearly felt the same way. Biden insisted that the Occupational Safety and Health Administration (OSHA) had the right to force workers at businesses with more than 100 employees to require a COVID-19 vaccine. He was wrong, as usual.
Some experts weighed in on the decision. They insisted that the agency was overstepping its bounds. However, OSHA didn’t propose the mandate. The order to force an experimental drug on workers across the nation came from Joe Biden. OSHA was a pawn.
It is one of the most egregious power grabs in the history of American government. Thousands of Americans have already quit their jobs for fear the order would be upheld. Hopefully, these people will get their jobs back or seek legal relief in the courts.
More than 80 million Americans would have been affected by this unconstitutional decree. By blocking the mandate in a 6 to 3 vote, SCOTUS issued a scathing condemnation of Biden’s attempt to forcibly exercise unnecessary government control over citizens’ lives.
In a statement released by Biden, he insisted he was “disappointed”. Not nearly as disappointed as the thousands of Americans he has forced or would have forced out of a job. Biden also bemoaned that his mandate was “grounded squarely in both science and law.”
As we watch millions of vaccinated Americans get infected with the Omicron COVID-19 variant, that’s a complete lie. The U.S. Supreme Court slammed the door shut on Biden’s other falsehood. His dictatorial mandate was not grounded squarely in the law. It was unconstitutional.
If Americans do not elect a common sense counterbalance to Biden’s liberal socialist insanity, we will lose our democracy. It will be challenging three years for certain. However, the alternative will be unthinkable. We will not recognize our country otherwise.
A strong conservative-led counterbalance in both Houses of Congress will freeze Joe Biden’s liberal assault on democracy. Soon after he fumbles his way out of the White House, he will begin his own legacy; a legacy as the worst president in the history of this great nation.
******************************************
Pediatric Neurologist Dr. Ben Carson On Kids' COVID Vax: 'Just a Giant Experiment' - 'Doesn't Make Sense'
Pediatric neurologist Dr. Ben Carson appeared on Fox Businesses and told host Maria Bartiromo that the COVID vaccine for 5-11 year olds does not make sense, and described it as a "giant experiment."
Bartiromo asked Carson if he agrees with the CDC decision to vaccinate kids for COVID and he replied, “Uh, absolutely not!"
He continued, "The fact of the matter is, the mortality rate for children from COVID-19 is .025 which is very similar to the rate for seasonal flu—and we haven’t been going through these things for seasonal flu!”
“This is really just a giant experiment,” Carson said. “Do we want to put our children at risk when we don’t know why would we do a thing like that?” adding, “It makes no sense whatsoever.”
He declared that natural immunity “is very very effective,” including a “study by the Cleveland Clinic of 1,300 of their workers who had been previously infected, and NONE of them have been re-infected!”
Carson noted that the vaccine push is nothing more than a money grab.
https://dailypatriotreport.com/pediatric-neurologist-dr-ben-carson-on-kids-covid-vax-just-a-giant-experiment-doesnt-make-sense/ (Video at link)
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Monday, January 17, 2022
Rapid tests may not detect omicron early in infection
Rapid antigen tests for COVID-19 may not reliably detect the omicron variant during the first few days of infection, even when a person is shedding the virus in high enough quantities to be contagious, preliminary evidence hints.
For the new study, posted Wednesday (Jan. 5) to the preprint database medRxiv, researchers looked at 30 people from five different workplaces in New York and California, all of whom tested positive for SARS-CoV-2 in December 2021. Due to their workplace policies, each person was undergoing both daily rapid tests and daily PCR tests, which take longer to process but can detect smaller amounts of virus. People in the study used the Abbott BinaxNOW and Quidel QuickVue rapid antigen tests, which are both approved for use by the Food and Drug Administration (FDA).
Of the participants, all but one were likely infected with the omicron variant, based on how a genetic quirk of the variant shows up on PCR tests, the team noted in their report.
On the day of each person's first positive PCR test, and on the day after, their rapid tests all came back negative, STAT News reported. It wasn't until nearly two days after the positive PCR that any of the rapid tests came back positive. Across all the subjects, "the median time from first positive PCR to first detectable antigen positive was three days," the researchers wrote in their report.
That's despite the fact that, in 28 of the 30 cases, the amount of virus detected by PCR was high enough to infect other people on Day 1, STAT News reported. Through contact tracing, the team confirmed that in four of those cases, infected people passed on the virus to others while still testing negative on rapid tests.
"It's absolutely likely there were many more than four transmissions," lead author Blythe Adamson, the principal epidemiologist at Infectious Economics in New York and an employee of Flatiron Health, an affiliate of Roche, told STAT News. "We named four because there were four that were confirmed through contact tracing and epidemiology investigation. There were likely many more."
While the findings are worrisome, other early data and anecdotal reports hint there may be a way to make these tests more sensitive earlier on in infection, by swabbing the throat in addition to the nose, The New York Times reported. This idea still needs to be verified with further research. In the meantime, the study highlights the importance of isolating if you have any COVID-19 symptoms — even if you have a negative result on a rapid test.
A negative rapid test result is "not a ticket that allows you to go back to normal or to drop any other measures," Isabella Eckerle, a clinical virologist at the University of Geneva in Switzerland, told the Times. And in particular, people should exercise caution if they've tested negative on a rapid test but have symptoms consistent with COVID-19, or believe they've been exposed to the virus.
The new study has not yet been peer-reviewed, but its results do align with a recent update from the FDA. Based on the agency's own lab studies, "Early data suggests that antigen tests do detect the omicron variant but may have reduced sensitivity," the update reads. That said, reduced sensitivity in the lab doesn't always translate to reduced sensitivity in real-world applications, Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering, told The New York Times.
The new preprint hints that, indeed, this reduced sensitivity noted by the FDA may also translate to real-world test results, thus creating a lag between positive PCR results and positive rapid results. This does not mean rapid tests are useless — they can still detect the omicron variant, they just take longer to do so than PCR.
"Due to immediate turnaround time, frequent rapid antigen testing does slow transmission — and with a highly infectious variant frequent testing is needed, which is not realistic with PCR," Abbott spokesman John Koval told the Times. Plus, PCR tests may not be as readily available as at-home rapid tests. So rapid tests still have utility; people should just be wary of false-negative results, test themselves at least twice over two consecutive days following an exposure, and keep track of potential COVID-19 symptoms regardless of their test results, the Times reported.
The big question now is, why are the rapid tests less sensitive to the omicron variant? Rapid antigen tests detect proteins on the coronavirus's surface, and as the virus mutates, these proteins can become less recognizable to the test. Once these problem mutations are identified, "adjustments to existing tests can be undertaken by each developer with support from the FDA, if appropriate," FDA spokeswoman Stephanie Caccomo told the Times.
That said, the rapid tests may have a second Achilles heel: The FDA-approved rapid tests are only approved for use in the nose, not the throat or mouth. Anecdotal reports and preliminary studies have hinted that omicron may replicate faster in the mouth and throat than it does in the nose, the Times reported. And the authors of the medRxiv paper found similar results in an analysis of five people in their study who took both nose swab- and saliva-based PCR tests. They found that, in these individuals, the amount of virus in their saliva peaked one to two days before that in their noses.
"The major unknown is what it has been for weeks now: Are the [rapid antigen tests] inherently less able to detect omicron, or is there less omicron to detect on nasal swabs?" John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, told STAT News. For now, the answer to that question remains unclear.
https://www.livescience.com/rapid-test-accuracy-omicron-coronavirus-infections
*******************************************************Vaccines Not Durable, Omicron Might Turn COVID-19 Endemic
Bill Gates, in a Twitter discussion Tuesday, said that the current COVID-19 vaccines were missing two key factors, and claimed that Omicron might bring about a wave of immunity in communities it passes through.
Microsoft co-founder and one of the world’s richest men, Gates has invested in vaccine research through his foundation and given prominent talks regarding the pandemic. Recently, he chatted regarding the current situation of COVID-19, vaccines, and related issues with Devi Sridhar, a professor at the University of Edinburgh where she holds a Personal Chair in Global Public Health.
When asked about a breakthrough that could result in the biggest difference in ending the pandemic, he talked about the efficacy of vaccines.
“The vaccines we have prevent severe disease and death very well but they are missing two key things. First they still allow infections (‘breakthrough’) and the duration appears to be limited. We need vaccines that prevent re-infection and have many years of duration,” Gates said.
The effectiveness of vaccines has been questioned, especially with regards to the Omicron variant. The high number of mutations on the variant’s spike protein increases “the possibility of immune escape,” according to Moderna President Stephen Hoge. Hoge added that the “dent in our vaccine’s efficacy” applies to all manufacturers.
Omicron has spread rapidly across the world, with 98.3 percent of infections in the United States now attributed to it. Although highly transmissible, international studies have shown that the strain poses milder symptoms in infected people.
Recently, a notable international health charity called for treating COVID-19 “like the common cold.” Dr. Mike Tildesley, a University of Warwick professor, has forecast COVID-19 evolving to become less severe and endemic. He said the Omicron variant is the beginning of that process. Gates has seconded this perspective.
“Once Omicron goes through a country then the rest of the year should see far fewer cases so COVID can be treated more like seasonal flu,” he said, while recommending yearly COVID-19 shots that would be needed for some time.
Gates talked about a lot of “misinformation” regarding him spreading on social media. “People like you and I and Tony Fauci have been subject to a lot of misinformation. I didn’t expect that. Some of it like me putting chips in arms doesn’t make sense to me—why would I want to do that?”
The billionaire then discussed the availability of vaccines around the world. Although there was demand, logistical issues and inefficient health systems prevented the adequate supply of vaccines in developing nations.
Regarding the Chinese authorities’ theory that the coronavirus emerged from a bat in a wet market located in Wuhan, Gates defended this argument. This is despite mounting evidence suggesting that the novel coronavirus, otherwise known as the CCP (Chinese Communist Party) virus escaped from a government lab in the Chinese city.
When Sridhar asked about the origin of the pandemic, Gates replied, “The data is pretty strong that it came from another species which is true for most pandemics. People will continue to speculate on this and we should make sure labs are careful. There will be future outbreaks coming from other species so we need to invest in being ready.”
********************************************
Virginia’s New GOP Governor Ends Vaccine Mandate for State Employees, Mask Mandates in Schools
Glenn Youngkin, the first Republican to win the state of Virginia since 2009, was sworn in as the state’s 74th governor on Jan. 15.
Within hours of his inauguration, he signed 11 executive actions including lifting the mask mandate in Virginia schools and “ending divisive concepts, including critical race theory, in public education.”
He also signed an executive directive rescinding the vaccine mandate for all state employees.
The 55-year-old former business executive, in his inauguration speech at Richmond, emphasized a “common path forward” with “our deep and abiding respect for individual freedom.” Youngkin vowed to strengthen and renew the “spirit of Virginia” associated with the history of the state as the home of American democracy. He credited Virginians with the spirit of tenacity, grit, and resilience.
Youngkin said he was “ready to lead and serve, starting on day one,” and it would start in the classroom to get Virginia’s children “career and college ready.” The crowd of an estimated size of 6,000 burst into a loud cheer upon hearing from Youngkin that he would “remove politics from the classroom.”
“Virginia is open for business,” Youngkin promised to create 400,000 new jobs and 10,000 new startups in the four years of his administration by reducing regulations and increasing job-related training.
According to him, residents of the commonwealth will see the “largest tax rebate in Virginia’s history.” In addition, he promised to “fully fund” and “return respect to” law enforcement.
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Sunday, January 16, 2022
Covid-19 testing in the time of omicron
With omicron infections surging around the world, many countries are changing their coronavirus testing guidelines to better deal with the new variant and the huge number of cases it is causing. Here's what you need to know
Can you test positive for covid-19 without being infectious?
Even if you have had three doses of coronavirus vaccine, a positive lateral flow test (LFT) result means you are infectious to other people because virus protein is present in large quantities in your nose or throat. For that, the virus must be actively multiplying inside your cells.
However, PCR tests continue to give positive results for days to weeks after an infection, because they can detect tiny quantities of the virus’s genetic material, which aren’t necessarily infectious.
How have testing rules changed?
Many countries have lessened their restrictions for people with covid-19 since the start of the surge caused by the omicron variant. In the UK, the isolation period for infected people has been cut from 10 days to seven – as long as you get a negative result on two LFTs, also known as rapid antigen tests. These must be done on days six and seven, and carried out at least 24 hours apart. People should remain cautious around others and avoid those who are vulnerable, though.
Could the isolation period be shortened further?
In the US, the isolation period has been cut to five days for people who have no symptoms or whose symptoms are on the wane, although you should still wear a mask around other people for a further five days. The UK Health Security Agency (UKHSA) says it has no plans to follow suit.
Why do some people still test positive on day seven even though they feel well?
Symptoms may not reflect how much virus is present in a person’s throat or nose – they could have replicating virus but no symptoms and vice versa. “There’s huge variation in the length of infection, and huge variations in viral load,” says Al Edwards at the University of Reading, UK.
The UKHSA estimates that between 10 and 30 per cent of people will still be positive at day six – and that 5 per cent of people will still be positive at day 10, although the guidance says you no longer have to isolate on day 11, no matter what your LFT results show.
How about confirmatory PCR tests?
In the UK, people who test positive by LFT will no longer need to take a follow-up PCR test, a temporary change coming into effect on 11 January. This is because background levels of covid-19 are so high – with about 1 in 15 people infected in the last week of December – that a positive LFT result is currently less likely to be false.
Does this mean we can just rely on LFTs now?
No. Anyone in the UK with covid-19 symptoms but a negative LFT result must still take a PCR test to rule out an infection, because LFTs have too high a rate of false negatives – telling someone they are covid-19 free when they really are infected – to rely on them if you have symptoms. There are several reasons why LFTs are prone to false negatives, including people failing to swab their nose or throat properly and failing to mix the swab well with the testing fluid, says Edwards. “LFTs are only able to detect large amounts of virus.”
Are false negatives more likely with omicron?
Opinions differ. The UKHSA says initial investigations suggest that LFTs are as sensitive to omicron as they are to the delta variant that was predominant in most countries until December, although it is continuing further tests. But the US Food and Drug Administration has said LFTs may be less sensitive at detecting omicron.
It is possible that LFTs that only involve swabbing the nose may be more likely to give false negative results for omicron, because some studies have suggested that this variant is more likely to reach high levels in saliva before it does in nasal mucus. One very small US study put online last week suggests that in omicron infections, virus levels peaked in saliva one or two days before they did in nasal mucus, although this analysis included only five people.
“Omicron might be exacerbating that differential, where you have your throat and your salivary specimens turning positive earlier,” says Michael Mina at US testing company eMed. A study from South Africa also found that saliva swabs were generally more sensitive than nasal swabs for omicron, whereas it is the opposite pattern for the delta variant.
Should we switch to using throat swabs over nasal swabs?
Opinions differ there too. In the UK, LFTs made by Innova instruct users to take throat and nasal swabs, while others only use nasal swabs. In the US, only nasal LFTs are available, so people are less used to taking throat swabs. “If at all possible, put your swab in both your throat and nasal cavities,” Deenan Pillay at University College London said at last week’s meeting of Independent SAGE, an independent group of scientists in the UK. “If the swabs are shorter, stick your fingers in more to get to the back of the throat.”
But Edwards says people should only use tests exactly as instructed. “If you change the way you use a test, it doesn’t meet the manufacturer’s requirements. [Lower levels in the nose] are probably not going to make that much difference to how accurate the tests are. Most people will be either not infected or will have tons of virus. We should stick to doing tests the proper way.”
*************************************************
Repeat COVID-19 Vaccine Booster Shots Trigger Regulator Warning About Immune-System Risks
The EU’s drug regulator has expressed doubts about whether a second booster dose of the currently available COVID-19 vaccines would be a sustainable long-term approach.
“There is an emergency discussion around the possibility of giving a second booster dose with the same vaccine currently in use. Data has not yet been generated to support this approach,” Marco Cavaleri, the European Medicines Agency’s (EMA) head of vaccines strategy, told a media briefing.
He added later, “We would like to see this data before we can make any recommendation, but at the same time we are rather concerned about a strategy that [involves] repeated vaccinations within a short term.”
An additional vaccine booster shot “could be considered as part of a contingency plan,” but “repeated vaccinations within short intervals will not represent a sustainable long term strategy,” according to Cavaleri.
Concerns Over Immune Response
When asked to expand on his statements, Cavaleri said that for a hypothetical approach of giving vaccine booster shots frequently, such as every four months, “we will end up potentially having problems with immune response and immune response may end up not being as good as we would like it to be, so we should be careful in not overloading the immune system with repeated immunization.”
He also noted that continuous administration of boosters can also lead to fatigue in the population.
“It will be much better to start thinking about an administration of boosters that is more spaced in time,” Cavaleri said.
The EMA is in conversation with vaccine developers in case there’s a need to update the current vaccines, according to Cavaleri. But he said any change “would have to be coordinated globally.”
More data on the effect of the Omicron coronavirus variant on vaccines and a better understanding of the evolution of the current wave are needed to decide whether an Omicron-specific vaccine was needed.
“While a monovalent Omicron vaccine would represent an obvious candidate to be investigated, other options such as a multivalent vaccine cannot be ruled out as potential alternatives,” Cavaleri said.
A Strategy to ‘Anticipate the Next Move’
“It is important that there is a good discussion around the choice of the composition of the vaccine to make sure that we have a strategy that is not just reactive after the virus changes, but try to anticipate what could be the next move and try to come up with an approach that will be suitable in order to prevent a future variant that, in any case, will emerge,” Cavaleri said.
The EMA has called for a meeting with global regulators on Jan. 12, which will include officials from the U.S. Food and Drug Administration.
“Tomorrow we will be looking at all the evidence that we have so far with the current vaccine, so the extent by which they are still providing vaccine effectiveness and whether indeed we should still think that giving a booster shot at this point in time is the best strategy,” Cavaleri said.
He noted that the World Health Organization “will play a critical role” in decision-making.
Cavaleri noted that the CCP (Chinese Communist Party) virus, which causes COVID-19, “is still behaving as a pandemic virus, and the Omicron emergency is currently showing that.”
“So we should not forget we are still in a pandemic,” he said. “Nevertheless, with increase of immunity in the population and with Omicron there will be a lot of natural immunity taking place on top of vaccination, we will be vastly moving toward a scenario that will be closer to endemicity.”
Separately, he noted, “Ideally, if you want to move toward a scenario of endemicity, then such boosters should be synchronized with the arrival of the cold seasons in each of the hemispheres, similarly to what we’re doing with influenza vaccines.”
*****************************************************
Anti-viral chewing gum?
University of Pennsylvania scientists used saliva samples of COVID-19 patients to test a chewing gum laced with a plant-grown protein.
The protein traps the SARS-CoV-2 virus to reduce viral load in saliva and potentially hamper transmission.
According to the team of researchers, the chewing gum contains the ACE2 protein to neutralize the virus.
EurekAlert! noted:
The work, led by Henry Daniell at Penn’s School of Dental Medicine and performed in collaboration with scientists at the Perelman School of Medicine and School of Veterinary Medicine, as well as at The Wistar Institute and Fraunhofer USA, could lead to a low-cost tool in the arsenal against the COVID-19 pandemic. Their study was published in the journal Molecular Therapy.
“SARS-CoV-2 replicates in the salivary glands, and we know that when someone who is infected sneezes, coughs, or speaks some of that virus can be expelled and reach others,” says Daniell. “This gum offers an opportunity to neutralize the virus in the saliva, giving us a simple way to possibly cut down on a source of disease transmission.”
Since the experimental COVID-19 injections don’t prevent transmission, Daniell’s work provides an innovative solution to potentially reduce viral load.
Recent research indicates vaccinated and unvaccinated individuals can carry similar viral loads.
EurekAlert! explained how the scientists tested the chewing gum:
To test the chewing gum, the team grew ACE2 in plants, paired with another compound that enables the protein to cross mucosal barriers and facilitates binding, and incorporated the resulting plant material into cinnamon-flavored gum tablets. Incubating samples obtained from nasopharyngeal swabs from COVID-positive patients with the gum, they showed that the ACE2 present could neutralize SARS-CoV-2 viruses.
Those initial investigations were followed by others at The Wistar Institute and Penn Vet, in which viruses, less-pathogenic than SARS-CoV-2, were modified to express the SARS-CoV-2 spike protein. The scientists observed that the gum largely prevented the viruses or viral particles from entering cells, either by blocking the ACE2 receptor on the cells or by binding directly to the spike protein.
Finally, the team exposed saliva samples from COVID-19 patients to the ACE2 gum and found that levels of viral RNA fell so dramatically to be almost undetectable.
After the positive findings, the researchers have sought permission to conduct a clinical trial with COVID-19 positive patients.
The research remains in the beginning stages, but clinical trials proving the gum is safe and effective can potentially be a game-changer to prevent transmission.
The peer-reviewed study was published in the journal Molecular Therapy.
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Friday, January 14, 2022
Cannabis compounds can stop the virus that causes COVID-19 from entering human cells by binding to the spike protein and blocking it from infecting people, study finds
This will be a great excuse for potheads
The compounds are found in hemp and can be taken orally or combine with the coronavirus vaccine
Researchers at Oregon State University identified a pair of cannabinoid acids that bind to the SARS-CoV-2 spike protein, blocking a critical step in the process the virus uses to infect people.
The team found the cannabis compounds, which can be taken orally and are abundantly found in hemp, blocked the alpha and beta variants from infecting the human cells - but the team notes those are the only two variants studied in this research.
This means, according to the team, the compounds could prove successfully in blocking other coronavirus strains.
Richard van Breemen, a researcher with Oregon State's Global Hemp Innovation Center and study lead, said in a statement: 'These cannabinoid acids are abundant in hemp and in many hemp extracts.
'They are not controlled substances like THC, the psychoactive ingredient in marijuana, and have a good safety profile in humans.
'And our research showed the hemp compounds were equally effective against variants of SARS-CoV-2, including variant B.1.1.7, which was first detected in the United Kingdom, and variant B.1.351, first detected in South Africa.'
The specific compounds are cannabigerolic acid, or CBGA, and cannabidiolic acid, CBDA, and the spike protein is the same drug target used in COVID-19 vaccines and antibody therapy.
SARS-CoV-2, which is characterized by crown-like protrusions on its outer surface, features RNA strands that encode its four main structural proteins – spike, envelope, membrane and nucleocapsid – as well as 16 nonstructural proteins and several 'accessory' proteins, van Breemen said.
'Any part of the infection and replication cycle is a potential target for antiviral intervention, and the connection of the spike protein's receptor binding domain to the human cell surface receptor ACE2 is a critical step in that cycle,' he said.
'That means cell entry inhibitors, like the acids from hemp, could be used to prevent SARS-CoV-2 infection and also to shorten infections by preventing virus particles from infecting human cells.
'They bind to the spike proteins so those proteins can't bind to the ACE2 enzyme, which is abundant on the outer membrane of endothelial cells in the lungs and other organs.'
And using compounds to block virus-receptor interaction is nothing new: it has been used to treat HIV-1 and hepatitis.
'One of the primary concerns in the pandemic is the spread of variants, of which there are many, and B.1.1.7 and B.1.351 are among the most widespread and concerning,' said van Breeman.
'These variants are well known for evading antibodies against early lineage SARS-CoV-2, which is obviously concerning given that current vaccination strategies rely on the early lineage spike protein as an antigen.
'Our data show CBDA and CBGA are effective against the two variants we looked at, and we hope that trend will extend to other existing and future variants.'
*********************************************
Covid loses 90% of ability to infect within minutes in air – study
Coronavirus loses 90% of its ability to infect us within 20 minutes of becoming airborne – with most of the loss occurring within the first five minutes, the world’s first simulations of how the virus survives in exhaled air suggest.
The findings re-emphasise the importance of short-range Covid transmission, with physical distancing and mask-wearing likely to be the most effective means of preventing infection. Ventilation, though still worthwhile, is likely to have a lesser impact.
“People have been focused on poorly ventilated spaces and thinking about airborne transmission over metres or across a room. I’m not saying that doesn’t happen, but I think still the greatest risk of exposure is when you’re close to someone,” said Prof Jonathan Reid, director of the University of Bristol’s Aerosol Research Centre and the study’s lead author.
“When you move further away, not only is the aerosol diluted down, there’s also less infectious virus because the virus has lost infectivity [as a result of time].”
Until now, our assumptions about how long the virus survives in tiny airborne droplets have been based on studies that involved spraying virus into sealed vessels called Goldberg drums, which rotate to keep the droplets airborne. Using this method, US researchers found that infectious virus could still be detected after three hours. Yet such experiments do not accurately replicate what happens when we cough or breathe.
Instead, researchers from the University of Bristol developed apparatus that allowed them to generate any number of tiny, virus-containing particles and gently levitate them between two electric rings for anywhere between five seconds to 20 minutes, while tightly controlling the temperature, humidity and UV light intensity of their surroundings. “This is the first time anyone has been able to actually simulate what happens to the aerosol during the exhalation process,” Reid said.
The study, which has not yet been peer-reviewed, suggested that as the viral particles leave the relatively moist and carbon dioxide-rich conditions of the lungs, they rapidly lose water and dry out, while the transition to lower levels of carbon dioxide is associated with a rapid increase in pH. Both of these factors disrupt the virus’s ability to infect human cells, but the speed at which the particles dry out varies according to the relative humidity of the surrounding air.
When this was lower than 50% – similar to the relatively dry air found in many offices – the virus had lost around half of its infectivity within five seconds, after which the decline was slower and more steady, with a further 19% loss over the next five minutes. At 90% humidity – roughly equivalent to a steam or shower room – the decline in infectivity was more gradual, with 52% of particles remaining infectious after five minutes, dropping to about 10% after 20 minutes, after which these was no difference between the two conditions.
However, the temperature of the air made no difference to viral infectivity, contradicting the widely held belief that viral transmission is lower at high temperatures.
“It means that if I’m meeting friends for lunch in a pub today, the primary [risk] is likely to be me transmitting it to my friends, or my friends transmitting it to me, rather than it being transmitted from someone on the other side of the room,” said Reid. This highlights the importance of wearing a mask in situations where people cannot physically distance, he added.
The findings support what epidemiologists have been observing on the ground, said Dr Julian Tang, a clinical virologist at the University of Leicester, adding that “masks are very effective … as well as social distancing. Improved ventilation will also help – particularly if this is close to the source.”
Dr Stephen Griffin, associate professor of virology at the University of Leeds, emphasised the importance of ventilation, saying: “Aerosols will fill up indoor spaces rapidly in the absence of proper ventilation, so assuming the infected individual remains within the room, the levels of virus will be replenished.”
The same effects were seen across all three Sars-CoV-2 variants the team has tested so far, including Alpha. They hopes to start experiments with the Omicron variant in the coming weeks.
***************************************************
Obesity a big virus risk
The worst global health crisis in over 100 years has revealed many disturbing truths. Some, such as long-held beliefs surrounding the inherent corruption in big government and the liberal mainstream media, have been further substantiated.
However, a worldwide health crisis has a way of exposing other problems that most ignore. Since the very beginning of the pandemic, health experts have insisted that a particular segment of the population was far more at risk for serious illness from COVID-19.
When counting hospitalization rates from COVID-19, obese patients were dwarfing the number of otherwise physically healthy patients. Being excessively overweight was an obvious co-morbidity for serious COVID consequences.
Nevertheless, it has been all but ignored. No one wants to talk about how susceptible obese people are to being infected with COVID-19, and then requiring intense hospitalization. The factual statistics are astonishing.
One group of patients are at an even greater risk of serious illness from COVID-19 if they’re obese. A study by the U.S. Centers for Disease Control (CDC) shows that 66 percent of children over the age of 12 who are hospitalized classify as obese.
This is an astonishingly high number. However, when looking at the overall health statistics for the United States, no one should be surprised. We are, in fact, one of the least healthy nations in the world. Nearly three out of four people in the U.S. classify as overweight or obese.
Close to a quarter of children between 12 and 19 years of age meet the criteria for obese. These statistics are unacceptable. Medical experts have long warned of the tremendous health problem that obesity poses.
A raging virus, which leaked from a virology lab in Wuhan, China, has further exposed a stark reality. The United States of America, especially children, are grossly overweight. However, corrupt mainstream media outlets never discuss the obvious.
All they ever talk about is how the “unvaccinated” are putting everyone else at risk. This is not true. Corrupt politicians and their parrots in the mainstream media are broadcasting a lie. They are ignoring the facts.
Instead of pushing for more people to succumb to an experimental drug, we should be talking about improving our health. Never a word mentioned about this during prime-time news reports. Nevertheless, commercial breaks are still plastered with advertisements for fast food chains.
Healthy lifestyle choices are rarely discussed. The CDC study used a control group of children between the ages of 12 and 17-years-old. This study targeted six hospitals across six states. Two of the states, Texas and Florida, have lower rates of adolescent obesity compared with the national average.
However, collectively, the data showed more than two-thirds of the COVID hospitalization records for this age group were obese. These same children were reported to have one or more underlying conditions as well.
The length of the hospital stay for the 66 percent classifying as obese was twice that of otherwise healthy children. Obesity accounted for twice as many extended hospitalizations as respiratory ailments, such as asthma, did.
A respiratory virus affected double the number of children who were obese, as opposed to those who already struggled with respiratory challenges. Underlying medical conditions are clearly far more susceptible to serious illness from COVID-19 than otherwise healthy people.
The numbers correlate across all age groups, but are especially prevalent in children. In addition, co-morbidity is a huge contributor to more serious illness. Over 75 percent of the COVID-19 related deaths had at least four.
Corrupt government bureaucrats and the mainstream media refuse to talk about the “real science”. COVID-19 is a deadly virus. However, it targets individuals who are more susceptible. The virus is especially harsh on people who are obese.
Our medical experts should be focused on helping Americans to appreciate the benefits of good health. Instead of forcing otherwise healthy individuals to “comply”, we need to impress the importance of good health, beginning with our children.
Instead of demonizing individuals who do not choose to subject their bodies to an experimental medicine, target the people who are overwhelming the hospitals. Those who choose to be unhealthy and obese are the problem.
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Thursday, January 13, 2022
Pfizer boss says two doses provide ‘limited protection, if any’ against Omicron
Albert Bourla made the comments in an interview with Yahoo Finance after the company announced a new Omicron-specific version of the vaccine would be ready by March, with doses already being manufactured.
“We know that the two doses of the vaccine offer very limited protection, if any,” Dr Bourla said.
“The three doses with a booster, they offer reasonable protection against hospitalisation and deaths – against deaths, I think, very good, and less protection against infection. Now we are working on a new version of our vaccine, the 1.1, let me put it that way, that will cover Omicron as well. Of course we are waiting to have the final results, [but] the vaccine will be ready in March.”
In a separate interview with CNBC, Dr Bourla said Pfizer’s new vaccine would also target other variants currently circulating.
“The hope is that we will achieve something that will have way, way better protection particularly against infections,” he said.
“Because the protection against the hospitalisations and the severe disease – it is reasonable right now, with the current vaccines as long as you having, let’s say, the third dose.”
He added that it also remains unclear whether a fourth shot will become necessary, with Pfizer set to conduct experiments on the issue.
Omicron, which first emerged in southern Africa in November, quickly swept the world, overtaking Delta to become the most dominant strain and casting concern over the efficacy of existing vaccines.
The Pfizer and Moderna vaccines – both of which have been distributed in Australia – are only about 10 per cent effective at preventing symptomatic infection from Omicron 20 weeks after the second dose, a study from the UK Health Security Agency found.
While two doses still provide good protection against severe illness, the study found that booster shots increased protection against symptomatic infection to 75 per cent.
Pfizer claims its own studies show a third dose of its vaccine produces a 25-fold increase in neutralising antibodies against the new strain.
Early in 2021, Dr Bourla had said data showed Pfizer’s vaccine “was 100 per cent effective against severe Covid-19”.
Writing in The Wall Street Journal on Sunday, Nobel prize-winning virologist Luc Montagnier and constitutional scholar Jed Rubenfeld argued the rise of Omicron had made the Biden administration’s vaccine mandates “obsolete”.
“It would be irrational, legally indefensible and contrary to the public interest for government to mandate vaccines absent any evidence that the vaccines are effective in stopping the spread of the pathogen they target,” they wrote.
“Yet that’s exactly what’s happening here.”
They pointed to the World Health Organisation’s (WHO) position on vaccine mandates, which states that “if mandatory vaccination is considered necessary to interrupt transmission chains and prevent harm to others, there should be sufficient evidence that the vaccine is efficacious in preventing serious infection and/or transmission”.
For Omicron, they noted, “there is as yet no such evidence” and moreover, “the little data we have suggests the opposite”.
“One preprint study found that after 30 days the Moderna and Pfizer vaccines no longer had any statistically significant positive effect against Omicron infection, and after 90 days, their effect went negative – i.e. vaccinated people were more susceptible to Omicron infection,” they wrote.
“Confirming this negative efficacy finding, data from Denmark and the Canadian province of Ontario indicate that vaccinated people have higher rates of Omicron infection than unvaccinated people.”
Dr Montagnier and Mr Rubenfeld added that while there was “some early evidence” that boosters may reduce Omicron infections, “the effect appears to wane quickly, and we don’t know if repeated boosters would be an effective response to the surge of Omicron”.
Their comments come after the UK’s head vaccine adviser, Professor Sir Andrew Pollard, who helped develop the Oxford-AstraZeneca vaccine, called for an end to ongoing mass vaccination.
“It really is not affordable, sustainable or probably even needed to vaccinate everyone on the planet every four to six months,” Prof Pollard told BBC Radio 4’s Today program. “In the future, we need to target the vulnerable.”
On Monday, WHO called on vaccine makers to review the “strain composition” of the current vaccines in the face of Omicron.
“The Technical Advisory Group on Covid-19 Vaccine Composition considers that Covid-19 vaccines that have high impact on prevention of infection and transmission, in addition to the prevention of severe disease and death, are needed and should be developed,” WHO said in a statement.
“Until such vaccines are available, and as the SARS-CoV-2 virus evolves, the composition of current Covid-19 vaccines may need to be updated, to ensure that Covid-19 vaccines continue to provide WHO-recommended levels of protection against infection and disease by variants of concern, including Omicron and future variants.”
*********************************************
Expert reveals Covid-19 causing fewer hospitalisations than influenza
Coronavirus is sending fewer people to the hospital than a bad flu season despite cases threatening to top 100,000 around Australia.
Australian National University professor Peter Collignon said it was important to have perspective when looking at Covid hospitalisation and ICU numbers.
He said there were fewer hospital patients with Covid than those admitted with influenza during a recent winter.
'We're seeing a lot of people in hospital and a lot of people in ICU but we need to keep it in perspective,' he said on the Today show Wednesday.
'It's still less than what we often see in winter with influenza, for instance, a number of years ago, and it seems to be less of an issue than even six months ago with the proportion of infected people going into hospital.'
Professor Collignon said Australia's high vaccination rate meant a smaller proportion of people required care in hospital, or dying.
'So much so, that if you're vaccinated your risk is probably similar to a season of influenza, it's the one or two million unvaccinated adults we still have who are disproportionately in hospital and disproportionately in ICU,' he said.
The expert reminded people worried about being infected with the virus that Australians didn't have access to vaccines a year ago.
He said those who had their booster shot had a 'much, much lower chance of coming into serious grief than a year ago'.
'A lot of us are going to get Covid over the next year or two, but the consequences now for serious disease - which is what matters - is so much less than a year ago, we need to come to terms with that,' he said.
He said it was important to get more staff on the ground, decrease the fear level in society and ensure those vulnerable were at 'the front of the queue' for care.
Professor Collingnon was asked when he predicted Australia would hit the peak of the Omicron wave, and if infections would get worse before they got better.
'My view is that it should start flattening out in at least in the next week, a lot of the cases we're seeing is mainly being spread by people in their 20s and 30s, and you can see why because they were locked down for so long,' he replied.
'So as people are moving around less, more on holiday and interacting with large numbers less I think the numbers will come down.'
He said hospitalisations tended to lag five to seven days after infections levelled out, which he said were high, but not exponential.
Professor Collignon added that data observed from the Delta variant revealed that if a vaccinated person is naturally infected with Covid they build better immunity against the virus than what a booster shot could provide.
'Providing you're vaccinated, and if you're unlucky enough to get Omicron, you are likely to have longer-lasting immunity than even with a booster,' he explained.
'Natural infection tends to give you long-lasting immunity mainly because you're exposed to more parts of the virus rather than just the spike protein, which is the vaccine strategy.'
He urged unvaccinated people not to attempt to be infected naturally for the benefit of immunity as the chances of death or serious illness were much higher.
Experts predict Australia Day could be the day Omicron finally peaks in the major cities and the country could return to normal after that.
Major Australian cities could see a dramatic drop off in Covid-19 infections by the end of January as the Omicron surge 'runs out' of 'core' carriers to infect.
While new Covid cases topped 84,000 Australia-wide on Tuesday - including 38,000 in Victoria, 26,000 in NSW and 20,466 in Queensland - there are underlying signs that tally could dramatically improve by the end of this month.
So many of Omicron major carriers, people aged between 20 and 30, have been exposed already that the virus would began failing to reproduce when it meets people with immunity.
Initially that will happen in hotspots where the virus has run rampant, including areas of Melbourne and Sydney, and in Newcastle.
Catherine Bennett, chair of epidemiology at Deakin University, predicted the wave would start to turn around in about two weeks, before the end of January
*********************************************
Also see my other blogs. Main ones below:
http://edwatch.blogspot.com (EDUCATION WATCH)
http://antigreen.blogspot.com (GREENIE WATCH)
http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)
http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)
http://snorphty.blogspot.com/ (TONGUE-TIED)
*************************************
Subscribe to:
Posts (Atom)
